Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm
暂无分享,去创建一个
[1] M. Kielian,et al. Differential roles of two conserved glycine residues in the fusion peptide of Semliki Forest virus. , 2001, Virology.
[2] Winfried Weissenhorn,et al. Virus membrane fusion , 2007, FEBS Letters.
[3] J. Hoxie,et al. The Stoichiometry of Trimeric SIV Glycoprotein Interaction with CD4 Differs from That of Anti-envelope Antibody Fab Fragments* , 2001, The Journal of Biological Chemistry.
[4] William C. Olson,et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.
[5] P. Paterlini-Bréchot,et al. Cytobiological consequences of calcium-signaling alterations induced by human viral proteins. , 2006, Biochimica et biophysica acta.
[6] G. Melikyan,et al. Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane. , 2005, Molecular biology of the cell.
[7] M. Liao,et al. Functions of the Stem Region of the Semliki Forest Virus Fusion Protein during Virus Fusion and Assembly , 2006, Journal of Virology.
[8] W. Greene,et al. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes , 2002, Nature Biotechnology.
[9] D. Covell,et al. pH-dependent fusion of vesicular stomatitis virus with Vero cells. Measurement by dequenching of octadecyl rhodamine fluorescence. , 1987, The Journal of biological chemistry.
[10] R. Epand,et al. Fusion peptides and the mechanism of viral fusion. , 2003, Biochimica et biophysica acta.
[11] J. Nagle,et al. HIV-1 fusion peptide decreases bending energy and promotes curved fusion intermediates. , 2007, Biophysical journal.
[12] T. Dragic,et al. An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry. , 2006, Virology.
[13] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[14] Renate Kunert,et al. Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides , 2004, Journal of Virology.
[15] M. Martin,et al. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1 , 1994, Journal of virology.
[16] M. Kozlov,et al. Membranes of the world unite! , 2006, The Journal of cell biology.
[17] S. A. Gallo,et al. The HIV Env-mediated fusion reaction. , 2003, Biochimica et biophysica acta.
[18] E. Delwart,et al. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[19] G. Melikyan,et al. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. , 2000, Molecular biology of the cell.
[20] P. Bronk,et al. Multiple Local Contact Sites are Induced by GPI‐Linked Influenza Hemagglutinin During Hemifusion and Flickering Pore Formation , 2000, Traffic.
[21] R. Blumenthal,et al. Role of the Membrane-Proximal Domain in the Initial Stages of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein-Mediated Membrane Fusion , 1999, Journal of Virology.
[22] R. Ruigrok,et al. Photolabeling Identifies a Putative Fusion Domain in the Envelope Glycoprotein of Rabies and Vesicular Stomatitis Viruses (*) , 1995, The Journal of Biological Chemistry.
[23] R. Doms. Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. , 2000, Virology.
[24] F. Diaz-Griffero,et al. Endocytosis Is a Critical Step in Entry of Subgroup B Avian Leukosis Viruses , 2002, Journal of Virology.
[25] A. Helenius,et al. Rab7 Associates with Early Endosomes to Mediate Sorting and Transport of Semliki Forest Virus to Late Endosomes , 2005, PLoS biology.
[26] P S Kim,et al. Mechanisms of viral membrane fusion and its inhibition. , 2001, Annual review of biochemistry.
[27] R. Lamb,et al. Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures , 2005, Virology.
[28] S. Harrison. Viral membrane fusion , 2008, Nature Structural &Molecular Biology.
[29] C. Weiss,et al. Mutational Analysis of Residues in the Coiled-Coil Domain of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 , 1998, Journal of Virology.
[30] H. Katinger,et al. Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. , 2007, Biochemistry.
[31] D. Kabat,et al. Kinetic Factors Control Efficiencies of Cell Entry, Efficacies of Entry Inhibitors, and Mechanisms of Adaptation of Human Immunodeficiency Virus , 2005, Journal of Virology.
[32] John P. Moore,et al. Ternary Complex Formation of Human Immunodeficiency Virus Type 1 Env, CD4, and Chemokine Receptor Captured as an Intermediate of Membrane Fusion , 2005, Journal of Virology.
[33] Michael M. Kozlov,et al. Membrane Hemifusion: Crossing a Chasm in Two Leaps , 2005, Cell.
[34] A. Pelchen-Matthews,et al. Endocytosis in Viral Replication , 2000, Traffic.
[35] L. Chernomordik,et al. Biomembrane fusion: a new concept derived from model studies using two interacting planar lipid bilayers. , 1987, Biochimica et biophysica acta.
[36] Min Lu,et al. Structural and Functional Analysis of Interhelical Interactions in the Human Immunodeficiency Virus Type 1 gp41 Envelope Glycoprotein by Alanine-Scanning Mutagenesis , 2001, Journal of Virology.
[37] H. Kräusslich,et al. Involvement of Clathrin-Mediated Endocytosis in Human Immunodeficiency Virus Type 1 Entry , 2005, Journal of Virology.
[38] N. Demaurex,et al. Endosome-to-cytosol transport of viral nucleocapsids , 2005, Nature Cell Biology.
[39] G. Melikyan,et al. A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle. , 2004, Biophysical journal.
[40] H. Kräusslich,et al. Interactions of human retroviruses with the host cell cytoskeleton. , 2006, Current opinion in microbiology.
[41] A. Trkola,et al. Estimating the Stoichiometry of Human Immunodeficiency Virus Entry , 2008, Journal of Virology.
[42] P. S. Kim,et al. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. , 1995, Biochemistry.
[43] Shibo Jiang,et al. Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational Changes , 2004, Journal of Virology.
[44] Joseph Sodroski,et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.
[45] L. Chernomordik,et al. Viral and Developmental Cell Fusion Mechanisms: Conservation and Divergence , 2008, Developmental Cell.
[46] B. Sodeik,et al. Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell , 2006, Cellular microbiology.
[47] C. Broder,et al. Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion. , 2000, Experimental and molecular pathology.
[48] A. Sanchez,et al. Mutational Analysis of the Putative Fusion Domain of Ebola Virus Glycoprotein , 1999, Journal of Virology.
[49] V. Markin,et al. Membrane fusion: stalk model revisited. , 2002, Biophysical journal.
[50] M. Imai,et al. Dual Wavelength Imaging Allows Analysis of Membrane Fusion of Influenza Virus inside Cells , 2006, Journal of Virology.
[51] L. Tamm. Hypothesis: spring-loaded boomerang mechanism of influenza hemagglutinin-mediated membrane fusion. , 2003, Biochimica et biophysica acta.
[52] Ji Ming Wang,et al. Role of Cholesterol in Human Immunodeficiency Virus Type 1 Envelope Protein-Mediated Fusion with Host Cells , 2002, Journal of Virology.
[53] S. Blacklow,et al. The Mature Avian Leukosis Virus Subgroup A Envelope Glycoprotein Is Metastable, and Refolding Induced by the Synergistic Effects of Receptor Binding and Low pH Is Coupled to Infection , 2004, Journal of Virology.
[54] J. Lineberger,et al. Nef Does Not Affect the Efficiency of Human Immunodeficiency Virus Type 1 Fusion with Target Cells , 2003, Journal of Virology.
[55] M. Kozlov,et al. [Possible mechanism of membrane fusion]. , 1983, Biofizika.
[56] F S Cohen,et al. A quantitative model for membrane fusion based on low-energy intermediates , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[57] P. S. Kim,et al. A spring-loaded mechanism for the conformational change of influenza hemagglutinin , 1993, Cell.
[58] D. Kabat,et al. An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations. , 2007, Journal of molecular biology.
[59] M. Kielian. Class II virus membrane fusion proteins. , 2006, Virology.
[60] Nathan M. Sherer,et al. Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells , 2005, The Journal of cell biology.
[61] S. Durell,et al. What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review). , 1997, Molecular membrane biology.
[62] S. Goff,et al. Retroviral proteins that interact with the host cell cytoskeleton. , 2007, Current opinion in immunology.
[63] Yonathan Kozlovsky,et al. Stalk model of membrane fusion: solution of energy crisis. , 2002, Biophysical journal.
[64] P. Earl,et al. Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers , 1992, Journal of Virology.
[65] J. Zimmerberg,et al. Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines , 2001, The Journal of cell biology.
[66] S. A. Gallo,et al. Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion , 2006, Retrovirology.
[67] J. Zimmerberg,et al. Bending membranes to the task: structural intermediates in bilayer fusion. , 1995, Current opinion in structural biology.
[68] J. Lepault,et al. Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited , 2008, Cellular and Molecular Life Sciences.
[69] G. Melikyan,et al. HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. , 2003, Molecular biology of the cell.
[70] S. Pelletier,et al. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers , 1996, The Journal of cell biology.
[71] F S Cohen,et al. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. , 1999, Molecular biology of the cell.
[72] Q. Sattentau,et al. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding , 1991, The Journal of experimental medicine.
[73] S. Durell,et al. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events , 1996, The Journal of cell biology.
[74] G. Lewis,et al. Antigenic Properties of the Human Immunodeficiency Virus Transmembrane Glycoprotein during Cell-Cell Fusion , 2002, Journal of Virology.
[75] J. Binley,et al. The Cytoplasmic Tail Slows the Folding of Human Immunodeficiency Virus Type 1 Env from a Late Prebundle Configuration into the Six-Helix Bundle , 2005, Journal of Virology.
[76] J. Sodroski,et al. Stoichiometry of Envelope Glycoprotein Trimers in the Entry of Human Immunodeficiency Virus Type 1 , 2005, Journal of Virology.
[77] S. A. Gallo,et al. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process. , 2001, Biochemistry.
[78] G. Whittaker,et al. Differential Requirements of Rab5 and Rab7 for Endocytosis of Influenza and Other Enveloped Viruses , 2003, Traffic.
[79] J. White,et al. Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. , 1990, Biochemistry.
[80] C. Broder,et al. Inhibitors of Protein-Disulfide Isomerase Prevent Cleavage of Disulfide Bonds in Receptor-bound Glycoprotein 120 and Prevent HIV-1 Entry* , 2002, The Journal of Biological Chemistry.
[81] Anna K Bellamy-McIntyre,et al. Functional Links between the Fusion Peptide-proximal Polar Segment and Membrane-proximal Region of Human Immunodeficiency Virus gp41 in Distinct Phases of Membrane Fusion* , 2007, Journal of Biological Chemistry.
[82] I. Jones,et al. Protein-disulfide Isomerase-mediated Reduction of Two Disulfide Bonds of HIV Envelope Glycoprotein 120 Occurs Post-CXCR4 Binding and Is Required for Fusion* , 2003, The Journal of Biological Chemistry.
[83] R. Dwek,et al. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure , 1996, Journal of virology.
[84] Nga Nguyen,et al. Peptides Trap the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Fusion Intermediate at Two Sites , 2003, Journal of Virology.
[85] G. Whittaker,et al. Dissecting virus entry via endocytosis. , 2002, The Journal of general virology.
[86] J. Sodroski,et al. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events , 1992, Journal of virology.
[87] G. Melikyan,et al. The process of membrane fusion: Nipples, hemifusion, pores, and pore growth , 2002 .
[88] K. Salzwedel,et al. Direct Evidence that C-Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Entry Bind to the gp41 N-Helical Domain in Receptor-Activated Viral Envelope , 2003, Journal of Virology.
[89] É. Cohen,et al. Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry , 2006, Retrovirology.
[90] T. Hope,et al. Physiological Levels of Virion-Associated Human Immunodeficiency Virus Type 1 Envelope Induce Coreceptor-Dependent Calcium Flux , 2006, Journal of Virology.
[91] M. Roth,et al. Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. , 1999, Molecular biology of the cell.
[92] R. Blumenthal,et al. Conformational changes and fusion activity of vesicular stomatitis virus glycoprotein: [125I]iodonaphthyl azide photolabeling studies in biological membranes. , 1997, Biochemistry.
[93] L. Hernandez,et al. Mutational Analysis of the Candidate Internal Fusion Peptide of the Avian Leukosis and Sarcoma Virus Subgroup A Envelope Glycoprotein , 1998, Journal of Virology.
[94] Michael J Rust,et al. Ligands for Clathrin-Mediated Endocytosis Are Differentially Sorted into Distinct Populations of Early Endosomes , 2006, Cell.
[95] L. Chernomordik,et al. Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion. , 2000, Molecular biology of the cell.
[96] M. Alizon,et al. Rescue of HIV-1 Receptor Function through Cooperation between Different Forms of the CCR5 Chemokine Receptor* , 2002, The Journal of Biological Chemistry.
[97] A. Kolokoltsov,et al. Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. , 2006, Journal of virological methods.
[98] G. Melikyan,et al. Evolution of intermediates of influenza virus hemagglutinin-mediated fusion revealed by kinetic measurements of pore formation. , 2001, Biophysical journal.
[99] G. Melikyan,et al. Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion , 2000, The Journal of cell biology.
[100] J. Bess,et al. Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling. , 2002, Virology.
[101] Kathryn L. Schornberg,et al. Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein , 2006, Journal of Virology.
[102] M. Liao,et al. Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion , 2005, The Journal of cell biology.
[103] J. Young,et al. Low pH Is Required for Avian Sarcoma and Leukosis Virus Env-Induced Hemifusion and Fusion Pore Formation but Not for Pore Growth , 2004, Journal of Virology.
[104] Y. Shai,et al. Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation. , 2000, Journal of molecular biology.
[105] R. Lamb,et al. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion , 2001, The EMBO journal.
[106] G. Melikyan,et al. The Energetics of Membrane Fusion from Binding, through Hemifusion, Pore Formation, and Pore Enlargement , 2004, The Journal of Membrane Biology.
[107] F. Richards,et al. The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. , 1991, The Journal of biological chemistry.
[108] B. Fehse,et al. Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus Entry , 2001, Journal of Virology.
[109] J. Cunningham,et al. Retroviral Entry Mediated by Receptor Priming and Low pH Triggering of an Envelope Glycoprotein , 2000, Cell.
[110] G. Melikyan,et al. Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement. , 2003, Virology.
[111] S. Whelan,et al. Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection , 2005, Science.
[112] K. Salzwedel,et al. Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[113] Shibo Jiang,et al. The function of coreceptor as a basis for the kinetic dissection of HIV type 1 envelope protein‐mediated cell fusion , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[114] S. A. Gallo,et al. Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41. , 2004, Biochemistry.
[115] J. Skehel,et al. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.
[116] R. Lamb,et al. Structural basis of viral invasion: lessons from paramyxovirus F. , 2007, Current opinion in structural biology.
[117] A. Helenius,et al. Vesicular Stomatitis Virus Entry Host Cell Factors and Functions Involved In , 2022 .
[118] D. Chan,et al. The Prefusogenic Intermediate of HIV-1 gp41 Contains Exposed C-peptide Regions* , 2003, The Journal of Biological Chemistry.
[119] J. Skehel,et al. Coiled Coils in Both Intracellular Vesicle and Viral Membrane Fusion , 1998, Cell.
[120] D. Grainger,et al. Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction , 2005, Retrovirology.
[121] C. Broder,et al. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. , 2007, Virus research.
[122] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[123] Kozlov Mm,et al. Possible mechanism of membrane fusion , 1983 .
[124] Thorsten Lang,et al. Membrane fusion. , 2002, Current opinion in cell biology.
[125] Mark Marsh,et al. Virus Entry: Open Sesame , 2006, Cell.
[126] G. Chang,et al. A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles. , 2008, Virology.
[127] Michael J Rust,et al. Visualizing infection of individual influenza viruses , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[128] A. Kolokoltsov,et al. Rapid and Sensitive Detection of Retrovirus Entry by Using a Novel Luciferase-Based Content-Mixing Assay , 2004, Journal of Virology.
[129] Joseph Sodroski,et al. Stoichiometry of Antibody Neutralization of Human Immunodeficiency Virus Type 1 , 2005, Journal of Virology.
[130] M. Kielian,et al. Fusion Induced by a Class II Viral Fusion Protein, Semliki Forest Virus E1, Is Dependent on the Voltage of the Target Cell , 2007, Journal of Virology.
[131] C. Weiss,et al. Capture of an early fusion-active conformation of HIV-1 gp41 , 1998, Nature Structural Biology.
[132] Kathryn L. Schornberg,et al. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. , 2008, Critical reviews in biochemistry and molecular biology.
[133] K. Stiasny,et al. Effect of Membrane Curvature-Modifying Lipids on Membrane Fusion by Tick-Borne Encephalitis Virus , 2004, Journal of Virology.
[134] J. Lepault,et al. Visualization of the Target-Membrane-Inserted Fusion Protein of Semliki Forest Virus by Combined Electron Microscopy and Crystallography , 2003, Cell.
[135] R. Blumenthal,et al. The role of glycosphingolipids in HIV signaling, entry and pathogenesis , 2003, Glycoconjugate Journal.
[136] S. Matsuyama,et al. Sequential Roles of Receptor Binding and Low pH in Forming Prehairpin and Hairpin Conformations of a Retroviral Envelope Glycoprotein , 2004, Journal of Virology.
[137] Don C. Wiley,et al. Structure of an unliganded simian immunodeficiency virus gp120 core , 2005, Nature.
[138] J. Skehel,et al. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin , 1995, Journal of virology.
[139] W. Ou,et al. Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion. , 2006, Virology.
[140] S. Roche,et al. Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers. , 2002, Virology.
[141] S. Durell,et al. Dilation of the Human Immunodeficiency Virus–1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41 , 1998, The Journal of cell biology.
[142] L. Tamm,et al. Viral Fusion Peptides: A Tool Set to Disrupt and Connect Biological Membranes , 2000, Bioscience reports.
[143] P. Klasse. Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. , 2007, Virology.
[144] M. Roth,et al. A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. , 2000, Molecular biology of the cell.
[145] R. Blumenthal,et al. Varying effects of temperature, Ca2+ and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins , 2000, FEBS letters.
[146] R. Blumenthal,et al. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. , 2003, Biochemistry.
[147] D. Kabat,et al. Cooperation of Multiple CCR5 Coreceptors Is Required for Infections by Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.
[148] P. Bugelski,et al. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120 , 1993, Journal of virology.
[149] C. Voisset,et al. Functional hepatitis C virus envelope glycoproteins , 2004, Biology of the cell.
[150] L. Ratner,et al. Actin Cytoskeletal Reorganizations and Coreceptor-Mediated Activation of Rac during Human Immunodeficiency Virus-Induced Cell Fusion , 2004, Journal of Virology.
[151] Michael D. Miller,et al. Low pH Is Required for Avian Sarcoma and Leukosis Virus Env-Dependent Viral Penetration into the Cytosol and Not for Viral Uncoating , 2004, Journal of Virology.
[152] D. Griffin,et al. Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins , 2005, The Journal of cell biology.
[153] K. Salzwedel,et al. Sequential CD4-Coreceptor Interactions in Human Immunodeficiency Virus Type 1 Env Function: Soluble CD4 Activates Env for Coreceptor-Dependent Fusion and Reveals Blocking Activities of Antibodies against Cryptic Conserved Epitopes on gp120 , 2000, Journal of Virology.
[154] E. Freed. HIV-1 and the host cell: an intimate association. , 2004, Trends in microbiology.
[155] H. I. Henderson,et al. The temperature arrested intermediate of virus-cell fusion is a functional step in HIV infection , 2006, Virology Journal.
[156] J. Moore,et al. Human Immunodeficiency Virus Type 1 Env with an Intersubunit Disulfide Bond Engages Coreceptors but Requires Bond Reduction after Engagement To Induce Fusion , 2003, Journal of Virology.
[157] Y. Gaudin. Rabies Virus-Induced Membrane Fusion Pathway , 2000, The Journal of cell biology.
[158] Ari Helenius,et al. How Viruses Enter Animal Cells , 2004, Science.
[159] T. Vorherr,et al. H+-induced Membrane Insertion of Influenza Virus Hemagglutinin Involves the HA2 Amino-terminal Fusion Peptide but Not the Coiled Coil Region* , 1996, The Journal of Biological Chemistry.
[160] P. Earl,et al. The ectodomain of HIV‐1 env subunit gp41 forms a soluble, alpha‐helical, rod‐like oligomer in the absence of gp120 and the N‐terminal fusion peptide. , 1996, The EMBO journal.
[161] F. Rey,et al. Virus membrane-fusion proteins: more than one way to make a hairpin , 2006, Nature Reviews Microbiology.
[162] M. Kozlov,et al. Lipids in biological membrane fusion , 1995, The Journal of Membrane Biology.
[163] G. Melikyan,et al. Membrane-Anchored Inhibitory Peptides Capture Human Immunodeficiency Virus Type 1 gp41 Conformations That Engage the Target Membrane prior to Fusion , 2006, Journal of Virology.
[164] David H. Schwartz,et al. Actin-Dependent Receptor Colocalization Required for Human Immunodeficiency Virus Entry into Host Cells , 1998, Journal of Virology.
[165] V. Robert-Hebmann,et al. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through Gαi-protein signalling , 2006, AIDS.
[166] P. Bronk,et al. The Pathway of Membrane Fusion Catalyzed by Influenza Hemagglutinin: Restriction of Lipids, Hemifusion, and Lipidic Fusion Pore Formation , 1998, The Journal of cell biology.
[167] P. Bates,et al. Heptad Repeat 2-Based Peptides Inhibit Avian Sarcoma and Leukosis Virus Subgroup A Infection and Identify a Fusion Intermediate , 2004, Journal of Virology.
[168] X. Zhuang,et al. Virus trafficking – learning from single-virus tracking , 2007, Nature Reviews Microbiology.
[169] C. Broder,et al. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. , 2004, Blood.
[170] S. Günther,et al. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1 , 1995, Journal of virology.
[171] M. Kielian,et al. Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein , 1991, Journal of virology.
[172] J. Young,et al. Imaging individual retroviral fusion events: from hemifusion to pore formation and growth. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[173] P. S. Kim,et al. HIV Entry and Its Inhibition , 1998, Cell.
[174] C. Bewley,et al. Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation. , 2005, Biochemistry.
[175] S. Zolla-Pazner,et al. Dissection of Human Immunodeficiency Virus Type 1 Entry with Neutralizing Antibodies to gp41 Fusion Intermediates , 2002, Journal of Virology.
[176] R. Dutch,et al. Role of the Simian Virus 5 Fusion Protein N-Terminal Coiled-Coil Domain in Folding and Promotion of Membrane Fusion , 2005, Journal of Virology.
[177] C. Martínez-A,et al. Statins Inhibit HIV-1 Infection by Down-regulating Rho Activity , 2004, The Journal of experimental medicine.